Agomelatine Impurity 10

Basic Information

View in Editor

CAS Number

4521-28-2

Molecular Formula

C11H14O3

Molecular Weight

194.23 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Melting Point

58.0 to 63.0 deg-C

Boiling Point

196°C/9.9mmHg

Density

1.116

Flash Point

129.3℃

Solubility

Slightly soluble in methanol. Insoluble in chloroform.

SMILES

View in Editor

COC1=CC=C(C=C1)CCCC(=O)O

InChI

InChI=1S/C11H14O3/c1-14-10-7-5-9(6-8-10)3-2-4-11(12)13/h5-8H,2-4H2,1H3,(H,12,13)

InChIKey

LZHMNCJMXQKSBY-UHFFFAOYSA-N

LogP

2.1025

Topological Polar Surface Area

46.53 Å²

Hydrogen Bond Donor/Acceptor

1 / 3

Complexity

171

Safety Information

View Safety Information

Hazard Statement

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

Synonyms & References

English

4-(4-Methoxyphenyl) Butyric Acid
4-(4-Methoxyphenyl)butyric acid, purum, >=97.0% (T)
GEO-01705
4-(4-methoxy-phenyl)-butyric-acid
NSC 407553
4-(4-Methoxyphenyl)butanoic acid
CS-W022000
TS-00290
4-(4-Methoxyphenyl)butanoic acid #
4521-28-2
M2037
W-200380
4-(4-methoxyphenyl) butanoic acid
4-(4-Methoxyphenyl)butyricacid
butanoic acid, 4-(4-methoxyphenyl)-
FT-0601288
DTXSID80196435
EN300-60117
ZTB8R8QC7J
NCGC00174327-01
NSC407553
Butyric acid, gamma-(p-methoxyphenyl)-
NSC-407553
4-(4-methoxy-phenyl)butanoic acid
MFCD00004404
A7121
HMS1538F17
4-(4-methoxyphenyl)butanoic acid;4-(4-Methoxyphenyl)butyric acid
Q63409579
4-(4-methoxyphenyl)butyric cid
4-(4-Methoxyphenyl)butyric acid

MDL Number

MFCD00004404

Customs Code

2918990090

FAQ

What regulatory guidelines apply to Agomelatine Impurity 10 (CAS: 4521-28-2)?

Agomelatine Impurity 10 (CAS: 4521-28-2) must comply with regulatory guidelines such as REACH in Europe, which requires registration, evaluation, and authorization of chemicals. In the United States, it is subject to regulation by the FDA, particularly in terms of safety and purity. EPA regulations might apply if the compound is used in environmental contexts. Additionally, it should adhere to GHS (Globally Harmonized System of Classification and Labeling of Chemicals) for labeling and safety data sheets.

Are there alternatives to Agomelatine Impurity 10 (CAS: 4521-28-2) in synthesis?

Alternatives to Agomelatine Impurity 10 (CAS: 4521-28-2) in synthesis include using more pure agomelatine or other melatonin receptor agonists. Isomers or analogs of agomelatine might also be considered, although their synthesis would require careful optimization to achieve the desired pharmacological profile.

What is the market or research trend for Agomelatine Impurity 10 (CAS: 4521-28-2)?

The research trend for Agomelatine Impurity 10 (CAS: 4521-28-2) is focused on understanding its impact on melatonin receptors and its role in sleep disorders. Market trends show increasing interest in melatonin receptor agonists, which could lead to further development of related compounds. However, regulatory and safety studies are essential to validate its therapeutic potential.

How should waste containing Agomelatine Impurity 10 (CAS: 4521-28-2) be handled?

Waste containing Agomelatine Impurity 10 (CAS: 4521-28-2) should be collected in appropriate containers and disposed of via incineration or professional waste disposal services. Environmental protection measures should include minimizing the release of harmful substances. Proper documentation of waste disposal and adherence to local and international regulations are crucial.